Retinoids: novel immunomodulators and tumour‐suppressive agents?
- 5 September 2012
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 167 (3) , 483-492
Abstract
Retinoids play important roles in the transcriptional activity of normal, degenerative and tumour cells. Retinoid analogues may be promising therapeutic agents for the treatment of immune disorders as different as type I diabetes and systemic lupus erythematosus. In addition, the use of retinoids in cancer treatment has progressed significantly in the last two decades; thus, numerous retinoid compounds have been synthesized and tested. In this paper, the actual or potential use of retinoids as immunomodulators or tumour-suppressive agents is discussed.Keywords
This publication has 142 references indexed in Scilit:
- Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activationCell Death & Differentiation, 2010
- Combination of N-(4-hydroxyphenyl) retinamide and genistein increased apoptosis in neuroblastoma SK-N-BE2 and SH-SY5Y xenograftsNeuroscience, 2009
- TH17 cells and regulatory T cells in primary immunodeficiency diseasesJournal of Allergy and Clinical Immunology, 2009
- From the diet to the nucleus: Vitamin A and TGF-β join efforts at the mucosal interface of the intestineSeminars in Immunology, 2009
- Vitamin effects on the immune system: vitamins A and D take centre stageNature Reviews Immunology, 2008
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialThe Lancet Oncology, 2008
- To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosisOncogene, 2003
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- The RXR heterodimers and orphan receptorsCell, 1995
- A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinomaNature, 1987